What is induction therapy for autologous stem cell transplanation?
Management of transplant-eligible myeloma patients in 2017
The epigenetics of multiple myeloma and the rationale for HDAC inhibitors
Promising new combinations in the treatment of myeloma
Comparing continuous and fixed duration myeloma treatment with triplets and doublets